Trial · NCT01206062
Adverse events72
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 72
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Hypotension | Cardiac disorders | Intensive Control of SBP | 48 | 4,678 | |
| other | Hypotension | Cardiac disorders | Standard Control of SBP | 27 | 4,683 | |
| other | Syncope | Nervous system disorders | Intensive Control of SBP | 56 | 4,678 | |
| other | Syncope | Nervous system disorders | Standard Control of SBP | 33 | 4,683 | |
| other | Bradycardia | Vascular disorders | Intensive Control of SBP | 17 | 4,678 | |
| other | Bradycardia | Vascular disorders | Standard Control of SBP | 10 | 4,683 | |
| other | Electrolyte Abnormality | General disorders | Intensive Control of SBP | 33 | 4,678 | |
| other | Electrolyte Abnormality | General disorders | Standard Control of SBP | 22 | 4,683 | |
| other | Injurious fall | General disorders | Intensive Control of SBP | 229 | 4,678 | |
| other | Injurious fall | General disorders | Standard Control of SBP | 222 | 4,683 | |
| other | Acute kidney injury or acute renal failure | Renal and urinary disorders | Intensive Control of SBP | 11 | 4,678 | |
| other | Acute kidney injury or acute renal failure | Renal and urinary disorders | Standard Control of SBP | 3 | 4,683 | |
| other | Serum sodium < 130 mmol/liter | General disorders | Intensive Control of SBP | 180 | 4,678 | |
| other | Serum sodium < 130 mmol/liter | General disorders | Standard Control of SBP | 100 | 4,683 | |
| other | Serum sodium > 150 mmol/liter | General disorders | Intensive Control of SBP | 6 | 4,678 | |
| other | Serum sodium > 150 mmol/liter | General disorders | Standard Control of SBP | 0 | 4,683 | |
| other | Serum potassium <3.0 mmol/liter | General disorders | Intensive Control of SBP | 114 | 4,678 | |
| other | Serum potassium <3.0 mmol/liter | General disorders | Standard Control of SBP | 74 | 4,683 | |
| other | Serum potassium >5.5 mmol/liter | General disorders | Intensive Control of SBP | 176 | 4,678 | |
| other | Serum potassium >5.5 mmol/liter | General disorders | Standard Control of SBP | 171 | 4,683 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01206062/events